AU2173297A - Primycin compound with cyclodextrin - Google Patents
Primycin compound with cyclodextrinInfo
- Publication number
- AU2173297A AU2173297A AU21732/97A AU2173297A AU2173297A AU 2173297 A AU2173297 A AU 2173297A AU 21732/97 A AU21732/97 A AU 21732/97A AU 2173297 A AU2173297 A AU 2173297A AU 2173297 A AU2173297 A AU 2173297A
- Authority
- AU
- Australia
- Prior art keywords
- primycin
- cyclodextrin
- compound
- primycin compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229920000858 Cyclodextrin Polymers 0.000 title 1
- -1 Primycin compound Chemical class 0.000 title 1
- 229950010664 primycin Drugs 0.000 title 1
- NYWSLZMTZNODJM-SDUQVVOESA-N primycin Natural products CCCC[C@H]1[C@H](O)[C@H](C)CC[C@@H](O)CCC[C@@H](O)CCC[C@@H](O)C(=C[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)C[C@H](O)C[C@@H](O)C[C@H](O)C[C@H](O)CCCCC(=C[C@@H](C)[C@@H](OC1=O)[C@H](C)[C@H](O)CCCNC(=N)N)C)C NYWSLZMTZNODJM-SDUQVVOESA-N 0.000 title 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9600847A HUP9600847A3 (en) | 1996-04-02 | 1996-04-02 | Nonstochiometric compds. of primycins with ciclodextrin derivatives, pharmaceutical compns. contg. the said compds. and process for preparing them |
| HU9600847 | 1996-04-02 | ||
| PCT/HU1997/000010 WO1997036935A1 (en) | 1996-04-02 | 1997-03-28 | Primycin compound with cyclodextrin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2173297A true AU2173297A (en) | 1997-10-22 |
Family
ID=89993853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU21732/97A Abandoned AU2173297A (en) | 1996-04-02 | 1997-03-28 | Primycin compound with cyclodextrin |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR023625A1 (hu) |
| AU (1) | AU2173297A (hu) |
| HU (1) | HUP9600847A3 (hu) |
| WO (1) | WO1997036935A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1328443A (zh) * | 1998-11-23 | 2001-12-26 | 宝洁公司 | 皮肤除臭和卫生消毒组合物 |
| PE20020300A1 (es) | 2000-08-22 | 2002-05-10 | Pharmacia Corp | Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco |
| US20060257488A1 (en) * | 2005-05-10 | 2006-11-16 | Cytophil, Inc. | Injectable hydrogels and methods of making and using same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU196822B (en) * | 1984-07-03 | 1989-01-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing primicin salts |
-
1996
- 1996-04-02 HU HU9600847A patent/HUP9600847A3/hu unknown
-
1997
- 1997-03-28 WO PCT/HU1997/000010 patent/WO1997036935A1/en active Application Filing
- 1997-03-28 AU AU21732/97A patent/AU2173297A/en not_active Abandoned
- 1997-04-02 AR ARP970101304A patent/AR023625A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR023625A1 (es) | 2002-09-04 |
| HU9600847D0 (en) | 1996-05-28 |
| HUP9600847A3 (en) | 1999-08-30 |
| WO1997036935A1 (en) | 1997-10-09 |
| HUP9600847A2 (hu) | 1998-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3485999A (en) | Neo-tryptophan | |
| AU9392998A (en) | Pack-a-pillow | |
| AU5290999A (en) | Simplified window-raiser - | |
| AU3522399A (en) | Carvedilol-galenics | |
| AU3437799A (en) | City-car | |
| AU3253699A (en) | Myxochelines | |
| AU5407599A (en) | Sphingolipid-desaturase | |
| AU8363398A (en) | Capotasto | |
| AU1707599A (en) | Retinoid-glitazone combinations | |
| AU5516599A (en) | Substituted 3-aryl-pyrazoles | |
| AU2609599A (en) | Sensor-coupling | |
| AU2173297A (en) | Primycin compound with cyclodextrin | |
| AU4511499A (en) | Substituted cyclooctadepsipeptides | |
| AU2069199A (en) | Codelets | |
| AU3204999A (en) | Futureball | |
| AU4507899A (en) | Substituted n-aryl-o-alkyl-carbamates | |
| AU1055399A (en) | Rollerboard | |
| AU3186599A (en) | High speed combination router-switch | |
| AU3347599A (en) | Aeromobile | |
| AU9347498A (en) | Imidazotriazolopyrimidines | |
| AU5223199A (en) | Bathtub-bathseat | |
| AU3819799A (en) | Methoximinomethyloxathiazines | |
| AU2840799A (en) | 1-phosphanorbornadienes | |
| AU1656100A (en) | Substituted 2-imino-thiazolines | |
| AU5744399A (en) | Substituted n-aryl-o-alkyl-carbamates |